Scpharmaceuticals Stock Price History
| SCPH Stock | USD 3.35 0.11 3.18% |
Below is the normalized historical share price chart for Scpharmaceuticals extending back to November 17, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Scpharmaceuticals stands at 3.35, as last reported on the 22nd of November, with the highest price reaching 3.53 and the lowest price hitting 3.35 during the day.
If you're considering investing in Scpharmaceuticals Stock, it is important to understand the factors that can impact its price. Scpharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.17, which indicates the firm had a -0.17% return per unit of risk over the last 3 months. Scpharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Scpharmaceuticals' Coefficient Of Variation of (601.01), risk adjusted performance of (0.12), and Variance of 13.13 to confirm the risk estimate we provide.
As of now, Scpharmaceuticals' Stock Based Compensation is increasing as compared to previous years. . As of now, Scpharmaceuticals' Price Book Value Ratio is increasing as compared to previous years. The Scpharmaceuticals' current Price To Book Ratio is estimated to increase to 6.81, while Price To Sales Ratio is projected to decrease to 14.22. Scpharmaceuticals Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 17th of November 2017 | 200 Day MA 4.6919 | 50 Day MA 4.3584 | Beta 0.14 |
Scpharmaceuticals |
Sharpe Ratio = -0.1733
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SCPH |
Estimated Market Risk
| 3.59 actual daily | 31 69% of assets are more volatile |
Expected Return
| -0.62 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.17 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Scpharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Scpharmaceuticals by adding Scpharmaceuticals to a well-diversified portfolio.
Price Book 5.4751 | Enterprise Value Ebitda (6.69) | Price Sales 5.7183 | Shares Float 21.2 M | Wall Street Target Price 18 |
Scpharmaceuticals Stock Price History Chart
There are several ways to analyze Scpharmaceuticals Stock price data. The simplest method is using a basic Scpharmaceuticals candlestick price chart, which shows Scpharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | September 16, 2024 | 5.51 |
| Lowest Price | November 18, 2024 | 3.35 |
Scpharmaceuticals November 22, 2024 Stock Price Synopsis
Various analyses of Scpharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Scpharmaceuticals Stock. It can be used to describe the percentage change in the price of Scpharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Scpharmaceuticals Stock.| Scpharmaceuticals Accumulation Distribution | 15,035 | |
| Scpharmaceuticals Price Daily Balance Of Power | (0.61) | |
| Scpharmaceuticals Price Action Indicator | (0.14) | |
| Scpharmaceuticals Price Rate Of Daily Change | 0.97 |
Scpharmaceuticals November 22, 2024 Stock Price Analysis
Scpharmaceuticals Stock Price History Data
The price series of Scpharmaceuticals for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 has a statistical range of 2.16 with a coefficient of variation of 12.89. The price distribution for the period has arithmetic mean of 4.52. The median price for the last 90 days is 4.41.| Open | High | Low | Close | Volume | ||
| 11/22/2024 | 3.48 | 3.53 | 3.35 | 3.35 | 294,854 | |
| 11/21/2024 | 3.36 | 3.50 | 3.28 | 3.46 | 267,675 | |
| 11/20/2024 | 3.50 | 3.60 | 3.27 | 3.36 | 309,099 | |
| 11/19/2024 | 3.30 | 3.58 | 3.25 | 3.52 | 374,947 | |
| 11/18/2024 | 3.46 | 3.54 | 3.31 | 3.35 | 408,156 | |
| 11/15/2024 | 3.32 | 3.48 | 3.08 | 3.46 | 1,588,293 | |
| 11/14/2024 | 3.50 | 3.65 | 3.25 | 3.36 | 4,152,624 | |
| 11/13/2024 | 4.01 | 4.01 | 3.80 | 3.91 | 404,062 | |
| 11/12/2024 | 4.23 | 4.23 | 3.93 | 3.93 | 381,825 | |
| 11/11/2024 | 4.25 | 4.25 | 4.17 | 4.23 | 140,001 | |
| 11/08/2024 | 4.33 | 4.40 | 4.18 | 4.21 | 176,093 | |
| 11/07/2024 | 4.35 | 4.50 | 4.26 | 4.32 | 223,662 | |
| 11/06/2024 | 4.42 | 4.50 | 4.31 | 4.34 | 210,729 | |
| 11/05/2024 | 4.02 | 4.08 | 4.02 | 4.07 | 94,813 | |
| 11/04/2024 | 4.09 | 4.11 | 4.00 | 4.03 | 85,717 | |
| 11/01/2024 | 4.21 | 4.27 | 4.05 | 4.07 | 146,602 | |
| 10/31/2024 | 4.44 | 4.44 | 4.15 | 4.15 | 142,553 | |
| 10/30/2024 | 4.44 | 4.60 | 4.39 | 4.46 | 314,164 | |
| 10/29/2024 | 4.32 | 4.51 | 4.27 | 4.43 | 141,442 | |
| 10/28/2024 | 4.26 | 4.51 | 4.26 | 4.37 | 193,856 | |
| 10/25/2024 | 4.17 | 4.29 | 4.08 | 4.20 | 205,884 | |
| 10/24/2024 | 4.37 | 4.41 | 4.06 | 4.18 | 339,091 | |
| 10/23/2024 | 4.38 | 4.55 | 4.28 | 4.37 | 186,065 | |
| 10/22/2024 | 4.43 | 4.60 | 4.39 | 4.41 | 122,275 | |
| 10/21/2024 | 4.51 | 4.58 | 4.35 | 4.42 | 161,658 | |
| 10/18/2024 | 4.39 | 4.55 | 4.33 | 4.53 | 160,567 | |
| 10/17/2024 | 4.45 | 4.45 | 4.32 | 4.39 | 80,206 | |
| 10/16/2024 | 4.31 | 4.50 | 4.26 | 4.41 | 370,546 | |
| 10/15/2024 | 4.21 | 4.28 | 4.17 | 4.26 | 116,914 | |
| 10/14/2024 | 4.23 | 4.32 | 4.08 | 4.20 | 147,634 | |
| 10/11/2024 | 4.09 | 4.27 | 4.06 | 4.23 | 253,773 | |
| 10/10/2024 | 3.90 | 4.14 | 3.81 | 4.08 | 452,236 | |
| 10/09/2024 | 3.98 | 4.11 | 3.87 | 3.94 | 263,325 | |
| 10/08/2024 | 4.04 | 4.10 | 3.82 | 3.98 | 607,020 | |
| 10/07/2024 | 4.24 | 4.32 | 4.06 | 4.07 | 442,760 | |
| 10/04/2024 | 4.43 | 4.43 | 4.25 | 4.28 | 200,745 | |
| 10/03/2024 | 4.30 | 4.42 | 4.30 | 4.34 | 238,759 | |
| 10/02/2024 | 4.14 | 4.41 | 4.12 | 4.36 | 313,902 | |
| 10/01/2024 | 4.56 | 4.56 | 4.17 | 4.21 | 390,518 | |
| 09/30/2024 | 4.58 | 4.63 | 4.33 | 4.56 | 377,720 | |
| 09/27/2024 | 4.46 | 4.75 | 4.46 | 4.61 | 211,285 | |
| 09/26/2024 | 4.70 | 4.77 | 4.31 | 4.42 | 574,405 | |
| 09/25/2024 | 4.77 | 4.80 | 4.63 | 4.64 | 308,986 | |
| 09/24/2024 | 4.84 | 4.88 | 4.73 | 4.77 | 240,554 | |
| 09/23/2024 | 5.23 | 5.23 | 4.80 | 4.81 | 339,805 | |
| 09/20/2024 | 5.28 | 5.34 | 5.08 | 5.18 | 502,627 | |
| 09/19/2024 | 5.63 | 5.63 | 5.17 | 5.26 | 249,595 | |
| 09/18/2024 | 5.52 | 5.55 | 5.23 | 5.43 | 435,717 | |
| 09/17/2024 | 5.50 | 5.56 | 5.38 | 5.51 | 285,909 | |
| 09/16/2024 | 5.50 | 5.65 | 5.43 | 5.51 | 348,175 | |
| 09/13/2024 | 5.39 | 5.54 | 5.34 | 5.49 | 475,772 | |
| 09/12/2024 | 5.15 | 5.40 | 5.11 | 5.31 | 274,942 | |
| 09/11/2024 | 5.00 | 5.14 | 4.98 | 5.11 | 205,063 | |
| 09/10/2024 | 5.09 | 5.09 | 4.97 | 5.00 | 185,747 | |
| 09/09/2024 | 5.10 | 5.22 | 5.01 | 5.05 | 117,095 | |
| 09/06/2024 | 5.22 | 5.30 | 4.99 | 5.11 | 272,680 | |
| 09/05/2024 | 5.13 | 5.19 | 4.98 | 5.19 | 172,428 | |
| 09/04/2024 | 4.97 | 5.14 | 4.88 | 5.09 | 591,037 | |
| 09/03/2024 | 5.06 | 5.17 | 4.88 | 4.95 | 203,130 | |
| 08/30/2024 | 5.07 | 5.13 | 4.93 | 5.09 | 126,239 | |
| 08/29/2024 | 4.95 | 5.11 | 4.90 | 5.04 | 94,329 |
About Scpharmaceuticals Stock history
Scpharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Scpharmaceuticals is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Scpharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Scpharmaceuticals stock prices may prove useful in developing a viable investing in Scpharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 38.5 M | 22.2 M | |
| Net Loss | -33.2 M | -34.8 M |
Scpharmaceuticals Quarterly Net Working Capital |
|
Scpharmaceuticals Stock Technical Analysis
Scpharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Scpharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Scpharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Scpharmaceuticals Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Scpharmaceuticals to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.81) | |||
| Total Risk Alpha | (1.09) | |||
| Treynor Ratio | (0.31) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Scpharmaceuticals Stock analysis
When running Scpharmaceuticals' price analysis, check to measure Scpharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scpharmaceuticals is operating at the current time. Most of Scpharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Scpharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scpharmaceuticals' price. Additionally, you may evaluate how the addition of Scpharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |